{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Erasca, Inc."},"Symbol":{"label":"Symbol","value":"ERAS"},"Address":{"label":"Address","value":"10835 ROAD TO THE CURE,SUITE 140 SUITE 300, SAN DIEGO, California, 92121, United States"},"Phone":{"label":"Phone","value":"+1 858 465-6511"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage programs (CNS-penetrant KRAS G12C and EGFR inhibitors), and seven discovery-stage programs targeting other key oncogenic drivers."},"CompanyUrl":{"label":"Company Url","value":"https://www.erasca.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Amy Grekowicz Parker","title":"Vice President-Clinical Operations"},{"name":"Jonathan E. Lim","title":"Chairman & Chief Executive Officer"},{"name":"Les Brail","title":"Senior Vice President-Early Clinical Development"},{"name":"Michael D. Varney","title":"Director, Chairman-Research & Development"},{"name":"Nik Chetwyn","title":"Chief Operating Officer"},{"name":"Robert Shoemaker","title":"Senior Vice President-Research"},{"name":"Shannon R. Morris","title":"Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}